Blood-Induced Joint Disease: The Confluence of Dysregulated Oncogenes, Inflammatory Signals, and Angiogenic Cues

Seminars in Hematology

Volumn 45, Issue SUPPL. 1, 2008, Pages

  Valentino, Leonard A ^a   Hakobyan, Narine ^a   Enockson, Candace ^a  

^a Rush Children's Hospital and Rush University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANGIOGENESIS; APOPTOSIS; ARTHROPATHY; ARTICLE; BLOOD COMPONENT; CELL PROLIFERATION; CLINICAL FEATURE; HEMARTHROSIS; HEMOPHILIA; HUMAN; INFLAMMATION; JOINT PRESSURE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SYNOVITIS;

ANIMALS; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HUMANS; JOINT DISEASES; MICE; SYNOVIAL MEMBRANE;

EID: 44649171502     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2008.03.017     Document Type: Article

References (59)

1. Mannucci P.M. Hemophilia and related bleeding disorders: A story of dismay and success. Hematology Am Soc Hematol Educ Program 1-9 (2002)
2. Ahlberg A. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand Suppl suppl 77 (1965) 3-132
3. Aronstam A., Rainsford S.G., and Painter M.J. Patterns of bleeding in adolescents with severe haemophilia A. Br Med J 1 (1979) 469-470
4. Marion J., Favre-Gilly J., Picault C.H., and Gauthier G. Discovery of hemophilia at the time of intervention for villous synovitis of the elbow. Hemostase 5 (1965) 69-71
5. König F. Diseases of the joint in bleeders, especially with regard to the diagnosis. Clin Orthop Relat Res 52 (1967) 5-11
6. Salavec M. [Joint manifestations in hemophilia]. Vnitr Lek 16 (1970) 21-28
7. Procházka J., Rocek V., Krc C., Vyslouzil F., and Procek J. [Joint lesions in hemophilia: clinical-x-ray study]. Vnitr Lek 21 (1975) 240-248
8. Holstein J. [Joint changes in hemophilia in the roentgenogram: Survey of 30 cases]. Dtsch Gesundheitsw 15 (1960) 2470-2476
9. Johnson J.B., Davis T.W., and Bullock W.H. Bone and joint changes in hemophilia; a long-term study in twelve Negro subjects. Radiology 63 (1954) 64-71
10. Nuss R., Kilcoyne R.F., Geraghty S., Shroyer A.L., Rosky J.W., Mawhinney S., et al. MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia 6 (2000) 162-169
11. Nuss R., Kilcoyne R.F., Rivard G.E., and Murphy J. Late clinical, plain x-ray and magnetic resonance imaging findings in haemophilic joints treated with radiosynoviorthesis. Haemophilia 6 (2000) 658-663
12. Handelsman J.E. The knee joint in hemophilia. Orthop Clin North Am 10 (1979) 139-173
13. Wen F.Q., Jabbar A.A., Chen Y.X., Kazarian T., Patel D.A., and Valentino L.A. c-myc proto-oncogene expression in hemophilic synovitis: In vitro studies of the effects of iron and ceramide. Blood 100 (2002) 912-916
14. Hakobyan N., Kazarian T., Jabbar A.A., Jabbar K.J., and Valentino L.A. Pathobiology of hemophilic synovitis I: Overexpression of mdm2 oncogene. Blood 104 (2004) 2060-2064
15. Hoots W.K., Rodriguez N., Boggio L., and Valentino L.A. Pathogenesis of haemophilic synovitis: Clinical aspects. Haemophilia 13 suppl 3 (2007) 4-9
16. Valentino L.A., Hakobyan N., Rodriguez N., and Hoots W.K. Pathogenesis of haemophilic synovitis: Experimental studies on blood-induced joint damage. Haemophilia 13 suppl 3 (2007) 10-13
17. Rodriguez-Merchan E.C. Haemophilic synovitis: Basic concepts. Haemophilia 13 suppl 3 (2007) 1-3
18. Rodríguez-Merchán E.C. Effects of hemophilia on articulations of children and adults. Clin Orthop Relat Res (1996) 7-13
19. Pollmann H., Richter H., Ringkamp H., and Jürgens H. When are children diagnosed as having severe haemophilia and when do they start to bleed?. A 10-year single-centre PUP study. Eur J Pediatr 158 suppl 3 (1999) S166-S170
20. Fischer K., van der Bom J.G., Mauser-Bunschoten E.P., Roosendaal G., Prejs R., de Kleijn P., et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 99 (2002) 2337-2341
21. Manco-Johnson M.M., Abshire T.C., Brown D., Buchanan G.R., Cohen A.R., DiMichele D., et al. Initial results of a randomized, prospective trial of prophylaxis to prevent joint disease in young children with factor VIII (FVIII) deficiency. Presented at the American Society of Hematology 47th Annual Meeting and Exposition, Atlanta, GA, December 12-13 (2005)
22. van Dijk K., Fischer K., van der Bom J.G., Grobbee D.E., and van den Berg H.M. Variability in clinical phenotype of severe haemophilia: The role of the first joint bleed. Haemophilia 11 (2005) 438-443
23. Pain in hemophilia. Lancet 1 (1973) 931-932
24. Lusher J.M. Assessment of response to treatment and design of clinical trials. Prog Clin Biol Res 150 (1984) 167-179
25. Choinière M., and Melzack R. Acute and chronic pain in hemophilia. Pain 31 (1987) 317-331
26. Rattray B., Nugent D.J., and Young G. Rofecoxib as adjunctive therapy for haemophilic arthropathy. Haemophilia 11 (2005) 240-244
27. Soucie J.M., Cianfrini C., Janco R.L., Kulkarni R., Hambleton J., Evatt B., et al. Joint range-of-motion limitations among young males with hemophilia: Prevalence and risk factors. Blood 103 (2004) 2467-2473
28. von Mackensen S. Quality of life and sports activities in patients with haemophilia. Haemophilia 13 suppl 2 (2007) 38-43
29. Fischer K., van der Bom J.G., and van den Berg H.M. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 9 suppl 1 (2003) 75-82
30. Poonnoose P.M., Thomas R., Keshava S.N., Cherian R.S., Padankatti S., Pazani D., et al. Psychometric analysis of the Functional Independence Score in Haemophilia (FISH). Haemophilia 13 (2007) 620-626
31. Remor E., Arranz P., Quintana M., Villar A., Jiménez-Yuste V., Diaz J.L., et al. Psychometric field study of the new haemophilia quality of life questionnaire for adults: The 'Hemofilia-QoL. ' Haemophilia 11 (2005) 603-610
32. Royal S., Schramm W., Berntorp E., Giangrande P., Gringeri A., Ludlam C., et al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 8 (2002) 44-50
33. MASAC: Medical and Scientific Advisory Council Recommendation Concerning Prophylaxis (Regular Administration of Clotting Factor Concentrate to Prevent Bleeding). MASAC Recommendation 170 (2006), National Hemophilia Foundation
34. World Federation of Hemophilia: Guidelines for the management of hemophilia, 2005. 2005. http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Gudelines_Mng_Hemophilia.pdf Accessed February 7, 2008
35. Berntorp E., Boulyjenkov V., Brettler D., Chandy M., Jones P., Lee C., et al. Modern treatment of haemophilia. Bull World Health Organ 73 (1995) 691-701
36. Hoots W.K., and Nugent D.J. Evidence for the benefits of prophylaxis in the management of hemophilia A. Thromb Haemost 96 (2006) 433-440
37. Pipe S.W., and Valentino L.A. Optimizing outcomes for patients with severe haemophilia A. Haemophilia 13 suppl 4 (2007) 1-16
38. Löfqvist T., Nilsson I.M., Berntorp E., and Pettersson H. Haemophilia prophylaxis in young patients-A long-term follow-up. J Intern Med 241 (1997) 395-400
39. Nilsson I.M. Experience with prophylaxis in Sweden. Semin Hematol 30 suppl 2 (1993) 16-19
40. Nilsson I.M. Is haemophilia prophylaxis achievable in the context of self-sufficiency?. Blood Coagul Fibrinolysis 5 suppl 4 (1994) S71-S75
41. Nilsson I.M., Berntorp E., Löfqvist T., and Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 232 (1992) 25-32
42. Nilsson I.M., Blombäck M., and Ahlberg A. Our experience in Sweden with prophylaxis on haemophilia. Bibl Haematol 34 (1970) 111-124
43. Nilsson I.M., Hedner U., and Ahlberg A. Haemophilia prophylaxis in Sweden. Acta Paediatr Scand 65 (1976) 129-135
44. Manco-Johnson M.J., Abshire T.C., Shapiro A.D., Riske B., Hacker M.R., Kilcoyne R., et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 357 (2007) 535-544
45. Centers for Disease Control and Prevention: Report on the Universal Data Collection Program 7 (No. 1):17 (2005)
46. Hacker M.R., Geraghty S., and Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 7 (2001) 392-396
47. Petrini P. Identifying and overcoming barriers to prophylaxis in the management of haemophilia. Haemophilia 13 suppl 2 (2007) 16-22
48. Mejia-Carvajal C., Hakobyan N., Enockson C., and Valentino L.A. The impact of joint bleeding and synovitis on physical ability and joint function in a murine model of haemophilic synovitis. Haemophilia 14 (2008) 119-126
49. Hakobyan N., Kazarian T., and Valentino L.A. Synovitis in a murine model of human factor VIII deficiency. Haemophilia 11 (2005) 227-232
50. Valentino L.A., and Hakobyan N. Histological changes in murine haemophilic synovitis: A quantitative grading system to assess blood-induced synovitis. Haemophilia 12 (2006) 654-662
51. Lin J., Hakobyan N., and Valentino L.A. Digital analysis of vascularity in hemophilic synovitis. Blood 108 (2006) 4070 abstr
52. Gazitt Y., Reddy S.V., Alcantara O., Yang J., and Boldt D.H. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: Iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. J Cell Physiol 187 (2001) 124-135
53. Aledort L.M., Haschmeyer R.H., and Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 236 (1994) 391-399
54. Hakobyan N, Enockson C, Cole AA, Sumner DR, Valentino LA: Experimental haemophilic arthropathy in a mouse model of a massive hemarthrosis: Gross, radiological, and histological changes. Haemophilia (in press)
55. Hilliard P., Funk S., Zourikian N., Bergstrom B.M., Bradley C.S., McLimont M., et al. Hemophilia joint health score reliability study. Haemophilia 12 (2006) 518-525
56. Manco-Johnson M.J., Nuss R., Funk S., and Murphy J. Joint evaluation instruments for children and adults with haemophilia. Haemophilia 6 (2000) 649-657
57. Manco-Johnson M.J., Pettersson H., Petrini P., Babyn P.S., Bergstrom B.M., Bradley C.S., et al. Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: Current status and future directions. Haemophilia 10 suppl 4 (2004) 88-93
58. Roosendaal G., Vianen M.E., Marx J.J., van den Berg H.M., Lafeber F.P., and Bijlsma J.W. Blood-induced joint damage: A human in vitro study. Arthritis Rheum 42 (1999) 1025-1032
59. Eger W., Schumacher B.L., Mollenhauer J., Kuettner K.E., and Cole A.A. Human knee and ankle cartilage explants: Catabolic differences. J Orthop Res 20 (2002) 526-534